The RNA polymerase II transcription factor TFIID comprises the TATA binding protein (TBP) and a set of TBP-associated factors (TAF II s). TFIID has been extensively characterized for yeast, Drosophila, and humans, demonstrating a high degree of conservation of both the amino acid sequences of the constituent TAF II Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. TFIID comprises the TATA binding protein (TBP) and TBP-associated factors (TAF II s) (3, 24) . A subset of TAF II s are present not only in TFIID but also in the SAGA, PCAF, STAGA, and TFTC complexes (5, 16, 22, 33, 38, 53) .
The RNA polymerase II transcription factor TFIID comprises the TATA binding protein (TBP) and a set of TBP-associated factors (TAF II s). TFIID has been extensively characterized for yeast, Drosophila, and humans, demonstrating a high degree of conservation of both the amino acid sequences of the constituent TAF II s and overall molecular organization. In recent years, it has been assumed that all the metazoan TAF II s have been identified, yet no metazoan homologues of yeast TAF II 47 (yTAF II 47 ) and yTAF II 65 are known. Both of these yTAF II s contain a histone fold domain (HFD) which selectively heterodimerizes with that of yTAF II 25 . We have cloned a novel mouse protein, TAF II 140, containing an HFD and a plant homeodomain (PHD) finger, which we demonstrated by immunoprecipitation to be a mammalian TFIID component. TAF II 140 shows extensive sequence similarity to Drosophila BIP2 (dBIP2) (dTAF II 155), which we also show to be a component of Drosophila TFIID. These proteins are metazoan homologues of yTAF II 47 as their HFDs selectively heterodimerize with dTAF II 24 and human TAF II 30 , metazoan homologues of yTAF II 25 . We further show that yTAF II 65 shares two domains with the Drosophila Prodos protein, a recently described potential dTAF II . These conserved domains are critical for yTAF II 65 function in vivo. Our results therefore identify metazoan homologues of yTAF II 47 and yTAF II 65.
Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. TFIID comprises the TATA binding protein (TBP) and TBP-associated factors (TAF II s) (3, 24) . A subset of TAF II s are present not only in TFIID but also in the SAGA, PCAF, STAGA, and TFTC complexes (5, 16, 22, 33, 38, 53) .
The function of TAF II s has been studied using in vitro transcription systems which have provided evidence that they act as specific coactivators by interacting directly with transcriptional activator proteins (48) . Such studies also indicated that TAF II s contribute to promoter recognition and promoter selectivity (8, 10, 49) . Genetic evidence obtained from TAF II knockout and depletion experiments and temperature-sensitive (TS) mutants indicates that TAF II s are involved in the control of gene expression in yeast and mammalian cells and that they act as antiapoptotic factors (11, 23, 37 ; for reviews, see references 2, 3, and 23).
TFIID has been characterized for Drosophila, humans, and yeast (7, 14, 40, 56) . After its initial purification, many subunits were rapidly identified and the corresponding genes were cloned. Sequence comparisons allowed the identification of TAF II s in each species sharing one or more conserved domains. Many of these domains correspond to structural motifs, such as the histone fold domain (HFD), the ␤-transducin repeat, and bromodomain, or catalytic domains, such as the histone acetyltransferase domain. These results indicate that the composition and organization of TFIID has been well conserved between yeast and humans (reviewed in reference 16).
In recent years, it has been assumed that all the mammalian TFIID components have been identified. Several observations, however, challenge this assumption. Characterization of highly purified yeast TFIID (yTFIID) has identified two novel TFIID subunits, yTAF II 48 (Mpt1) and yTAF II 65 (42, 45) . While yTAF II 48 is the homologue of human TAF II 135 (hTAF II 135) in yeast (18, 42) , no obvious metazoan homologues of yTAF II 65 have yet been identified. TAF II 65 contains an HFD which selectively heterodimerizes with yTAF II 25 (17) . Furthermore, a second yTAF II , yTAF II 47 (52) , contains an HFD and selectively heterodimerizes also with yTAF II 25 (17) . At present, no homologues of yTAF II 47 and yTAF II 65 in metazoans have been identified, yet a yTAF II shows high sequence similarity to the Drosophila protein BIP2 (bric-a-brac interacting protein 2), which also contains an HFD and PHD finger. We show that the dBIP2 HFD selectively and directly heterodimerizes with dTAF II 24 and that BIP2 is a component of dTFIID.
The Drosophila Prodos (PDS) is a protein essential for cell viability which has been shown to comprise an HFD which selectively heterodimerizes with dTAF II 16. Consequently, it has been proposed that PDS may be a dTFIID component (25) 
MATERIALS AND METHODS
Cloning of mTAF II 140 and hTAF II 140. The cDNA encoding mTAF II 140 HFD was isolated by reverse transcription (RT)-PCR using mouse F9 embryonal carcinoma cell RNA and oligonucleotide primers based on expressed sequence tag (EST) sequences. To isolate the full-length cDNA, an F9 embryonal carcinoma cDNA library was screened with the 32 P-labeled HFD fragment. A clone comprising the 5Ј untranslated region (UTR) and amino acids 1 to 340 was isolated. A second overlapping clone encoding amino acids 238 to 747 was isolated by screening the same library with oligonucleotide probes derived from EST sequences. The 3Ј end of the cDNA was cloned by RT-PCR using an oligonucleotide primer at amino acid 651 and primers in the 3Ј UTR derived from EST sequences. The partial cDNA sequences were cloned in pBSK and sequenced. The three cDNAs were assembled by overlapping PCR into two partially overlapping fragments. In one fragment, a BamHI site was introduced at nucleotide 1286 (GGCTCA-GGATCC) without changing the amino acid sequence. This fragment was cloned into the EcoRI-BamHI sites of expression vector pXJ41 (54) . A fragment from nucleotide 1286 to the end of the coding sequence was amplified with primers containing BamHI and XhoI sites, and the resulting fragment was cloned into the pXJ41 vector containing the 5Ј fragment, thus reconstituting the full open reading frame. The hTAF II 140 cDNA fragment containing the 5Ј UTR and genes for amino acids 1 to 727 was cloned by screening a HeLa cell cDNA library with an oligonucleotide corresponding to genes for amino acids 54 to 72 of the HFD based on EST sequences. All constructs were verified by automated DNA sequencing, and further details are available upon request.
Preparation of antibodies and immunoprecipitations. Antibodies against human and mouse TAF II 140 were generated against a synthetic peptide corresponding to amino acids 108 to 127 of hTAF II 140 (as indicated in Fig. 2 ) coupled to ovalbumin. Monoclonal antibodies were generated as previously described (32) . Two resulting monoclonal antibodies, 1C7 and 2F5, were used. The anti-BIP2 polyclonal antiserum was collected from rabbits immunized with a bacterially expressed glutathione S-transferase (GST)-fusion protein comprising amino acid residues 719 to 909 of the BIP2 protein. The anti-SAP130 and GCN5 antibodies were as previously described (M. Brand, J. G. Moogs, F. Lejeune, J. Stevenin, M. Oulad-Abdelghani, G. Almouzni, and L. Tora, submitted for publication). The anti-TBP monoclonal antibodies 2C1 and 3G3 and the anti-TAF II monoclonal antibodies were as previously described (6, 13, 27, 32, 35, 36) . The polyclonal antisera against dTBP, dTAF II 16, dTAF II 24 , and dTAF II 230 were as previously described (19, 28) . Immunoprecipitations of HeLa cell nuclear extracts with monoclonal antibody 2C1 and elutions with the epitope peptide were performed as previously described (6, 27, 35, 36) . Immunoprecipitations of Drosophila embryo extracts were performed as previously described (19) . Western blottings were performed by standard techniques, and the proteins were detected using an ECL kit (Amersham) and autoradiography.
Two-hybrid and coexpression assays. All yeast and bacterial expression vectors were constructed by PCR using primers with the appropriate restriction sites, and constructs were verified by automated DNA sequencing. Details of constructions are available on request. LexA fusions were constructed in the multicopy vector pBTM116 containing the TRP1 marker and the VP16 fusions were constructed in the multicopy vector pASV3 containing the LEU2 marker (18) , and assays were performed with the L40 strain as previously described (17, 50) . Quantitative ␤-galactosidase assays on individual L40 transformants were determined as previously described (18) . Reproducible results were obtained in several independent experiments, and the results of a typical experiment are shown in the figures.
Yeast complementation assays. Complementation assays were performed by the plasmid shuffle technique. Wild-type or mutated yTAF II s were cloned in the multicopy pAS3 plasmid with a LEU marker. All yeast strains were transformed by the LiAc technique. Yeast strain YSLS58 that was used for plasmid shuffling of TAF65 was derived from YSLS41 (45) by sporulation and tetrad dissection as previously described (17) . For complementation assays, the indicated rescue plasmids were transformed and the wild-type TAF (URA3) plasmid was shuffled out by two passages on media containing 5-fluoroorotic acid. In all experiments, cultures were grown in yeast-peptone-dextrose unless selection was necessary, in which case cultures were grown in the appropriate selective synthetic dextrose (SD) medium.
Immunostaining of Drosophila embryos. The 0-to 2-h and 2-to 24-h embryos were dechorionated, and antibody staining and diaminobenzidine visualization were performed as previously described (44) . The anti-BIP2 polyclonal antibody was diluted 1/3,000, and the peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG) was diluted 1/1,000.
Immunostaining of Drosophila salivary gland polytene chromosomes. Squashes of polytene chromosomes and antibody stainings were performed as previously described (57) . The anti-BIP2 primary antibody was diluted 1/200. The Cy3-conjugated secondary antibodies were diluted 1/500. DNA was stained with Hoechst 33258.
Nucleotide sequence accession numbers. The sequences reported here have been assigned the following EMBL database accession numbers: mTAF II 140, AJ292189; hTAF II 140, AJ292190; dTAF II 155, AJ292191.
RESULTS
HFD of mTAF II 140 heterodimerizes with hTAF II 30. We previously reported the existence of a putative HFD at the N terminus of yTAF II 47 which is necessary and sufficient for yeast viability (17) . This HFD shows strong sequence similarity to those of the hTAF II 135/ADA1/H2A family and mediates a selective heterodimerization with the yTAF II 25 HFD (17) . Database searches with the yTAF II 47 HFD identified several metazoan proteins with potential HFDs located at their N termini (reference 17 and Fig. 1A ).
To determine whether the HFD, which is identical in the human and murine proteins, would heterodimerize with hTAF II 30, two-hybrid experiments were performed in yeast by using LexA fusions of the hTAF II 30 HFD and VP16 fusions of the mouse protein (hereafter designated mTAF II 140). As previously described (17) , strong interactions between the HFDs of yTAF II (Fig. 1B, lanes 3 and 7) .
Direct heterodimerization of the mTAF II 140 and hTAF II 30 HFDs was tested by coexpression in E. coli (17, 18) . When expressed alone, a GST fusion of the yTAF II (Fig. 2) . Interestingly, mTAF II 140 also possesses a single PHD finger of the type Cys4-His-Cys3 originally described for the HAT3.1, Polycomb-like, and HRX proteins (1, 47) (sometimes also called the leukemia-associated protein [LAP] domain [43] ) at the C terminus of the protein. This PHD finger is preceded by a highly charged region comprising multiple lysine and glutamic acid residues and a region rich in proline and other small residues (Fig. 2) .
A partial cDNA encoding the first 727 amino acids of hTAF II 140 was also isolated by screening a HeLa cell cDNA library. Comparison with mTAF II 140 showed that the HFD was identical in the two proteins which otherwise share strong sequence similarity (Fig. 2) . Although we could not isolate a full-length clone for hTAF II 140, database searches identified a genomic clone and ESTs encoding a highly related PHD finger followed by a stop codon, as in mTAF II 140 (Fig.   4B ). This provides strong evidence for the existence of an hTAF II 140 protein with an overall structure analogous to that of mTAF II 140.
Monoclonal antibodies were raised against a peptide of hTAF II 140 downstream of the HFD (Fig. 2, underlined) , which is almost perfectly conserved between humans and mice. This monoclonal antibody recognizes a protein with a molecular mass of around 140 kDa in Cos cells transfected with an mTAF II 140 expression vector (Fig. 3A, lane 2) . Although no endogenous protein was seen with small amounts of control untransfected Cos cell extract (Fig. 3A, lane 1) , hTAF II 140 was clearly detected in more-concentrated HeLa cell nuclear extract (lane 3). The antibody also recognized a nuclear protein in HeLa cells in immunofluorescence experiments (data not shown).
To determine whether hTAF II 140 was a component of immunopurified TFIID, HeLa cell extracts were precipitated with the anti-TBP monoclonal antibody 2C1 (32) and the TFIID was eluted by using the 2C1 epitope peptide. HeLa cell TAF II 140 was clearly detected in the eluted TFIID (Fig. 3A,  lane 4) . HeLa cell TAF II 140 was also detected in immunopurified TFIID by using a second independent monoclonal antibody against the same peptide (Fig. 3B, lanes 2 and 3) , while neither TBP nor hTAF II 140 was detected in control immunoprecipitations using the anti-Flag antibody (lane 1). Reprobing of the immunoblot shows that previously identified TAF II s were present in the immunopurified TFIID as expected (Fig.  3B, lanes 4 to 6) . It is possible that TAF II 140 was originally 3 and 4) .
The anti-hTAF II 140 antibodies were also used to immunoprecipitate HeLa cell nuclear extracts. TBP, TAF II 30, TAF II 20, TAF II 18, and TAF II 55 as well as other TFIID components (data not shown) were all coprecipitated with TAF II 140 (Fig.  3C, lanes 1 to 4) . TAF II 30 is a component of the TFIID and TFTC complexes (5, 53) . To determine whether TAF II 140 is also present in TFTC, we asked whether TFTC-specific components could also be immunoprecipitated with the anti-TAF II 140 antibody. Incubation of the immunoblots with antibodies against hGCN5 and SAP130 (Brand et al., submitted) indicated that both were coprecipitated (Fig. 3C) . Therefore, the anti-TAF II 140 antibody precipitates both TFIID-specific subunits (TBP, hTAF II 18) and TFTC-specific subunits (SAP130, GCN5), indicating that it is present in both complexes.
BIP2 is a Drosophila TFIID subunit which heterodimerizes specifically with dTAF II 24. Database searches with mTAF II 140 show that it shares significant sequence similarity with the Drosophila protein BIP2 (Fig. 4A) . BIP2 was first identified (J.-C. Pointud and J.-L. Couderc, unpublished data) in a twohybrid screen using as bait the BTB (POZ) domain of bric-abrac 1, a regulatory protein required for several morphogenetic processes in Drosophila development (21, 45) . BIP2 contains an HFD in the N terminus and a PHD finger at the C terminus (Fig. 4A) . The PHD fingers of mouse and human TAF II 140 and BIP2 are more closely related to each other than to PHD fingers from other proteins (Fig. 4B) . The significant similarity with hTAF II 140 led us to ask whether BIP2 is a component of dTFIID.
We first determined whether the dBIP2 HFD would heterodimerize with those of dTAF II 16 or dTAF II 24. In yeast two-hybrid assays, the VP16-dBIP2 HFD chimera interacted strongly with the LexA-dTAF II 24 fusion, but only a weak interaction with dTAF II 16 was observed (Fig. 5A, lanes 1 and 2) . In contrast, no significant interaction with the HFDs of yTAF II 25 or hTAF II 30 was observed (lanes 3 to 5). This indicates that the dBIP2 HFD can discriminate between the HFDs of dTAF II 16 and dTAF II 24 . The selective interaction of the dBIP2 HFD with that of dTAF II 24 was also investigated by The GST-BIP2(2-89) fusion was solubilized by coexpression of full-length dTAF II 24 , for which a complex of the two was retained on the resin, whereas with dTAF II 16, no solubilization nor heterodimerization was observed (Fig. 5B, lanes 2 to 3) . Similarly, GST-BIP2(2-89) was solubilized by coexpression of the dTAF II 24 HFD(57-167), but not by the dTAF II A polyclonal anti-dBIP2 serum was generated (see Materials and Methods). In immunostaining, the anti-dBIP2 serum, but not the preimmune serum, recognized a ubiquitously expressed nuclear protein throughout Drosophila embryogenesis ( Fig. 6A and data not shown) . This antibody also localized the dBIP2 protein on polytene chromosomes exclusively in decondensed regions, both puffs and interbands (Fig. 6B , arrowheads) which correspond to RNA polymerase II start sites in transcriptionally active chromatin (30, 46) . In contrast, it is not found in the transcriptionally inactive heterochromatin around the centromere.
To determine whether dBIP2 is indeed a dTFIID subunit as suggested by its ability to interact with dTAF II 24, immunoprecipitation experiments were performed. The anti-dBIP2 serum recognized a protein with a mass of around 155 kDa in Drosophila embryo nuclear extracts (Fig. 5C, lane 1) . The embryo extract was precipitated with an antiserum against dTBP, which has previously been shown to precipitate the dTFIID complex (19, 29) . BIP2 was precipitated with the anti-dTBP sera (Fig.  5C, lane 4) , while no immunoprecipitation was seen using an irrelevant antiserum (lane 3), and the signal did not result from a spurious cross-reaction with the anti-TBP serum (lane 2). As a positive control, dTBP, dTAF II 42, dTAF II 24, and dTAF II 230 were also selectively precipitated by the anti-TBP serum (Fig.  5C and D, lanes 4, and data above results indicate that dBIP2 (dTAF II 155) is a TFIID component which selectively heterodimerizes with dTAF II 24. It has recently been reported that the PDS gene product contains an HFD and interacts specifically with dTAF II 16, leading to the idea that PDS is a TFIID subunit (25) 47 , it is possible that PDS may be a homologue of yTAF II 65. We have previously shown that, in addition to the HFD, a second domain of yTAF II 65 located between amino acids 103 and 510 was essential for its function in yeast (17) . As functional domains in TAF II s are often evolutionarily conserved, we examined this region for similarities with PDS. Sequence comparisons indicate that yTAF II 65 shares significant sequence similarity with PDS not only in the HFD but also in the region C terminal to the HFD (Fig. 7A) . Several highly conserved sequence motifs separated by insertions corresponding to potential loop regions in yTAF II 65 were observed. We therefore wished to determine whether this conserved domain (designated the TAPD) was essential for yTAF II 65 function.
Using the plasmid shuffle technique for yeast, we tested the ability of derivatives of yTAF II 65 with a deletion or mutation in the TAPD to complement the growth of a yTAF II 65 null strain. Deletion of the yTAF II 65 HFD does not abolish growth at 30°C but generates a temperature-sensitive phenotype (17) , indicating that the region containing the TAPD contributes to yTAF II 65 function. We made further deletions to determine more precisely the location of this functional domain of yTAF II 65.
Deletion of amino acids downstream of 406 did not affect the ability of yTAF II 65 to rescue the growth of the null strain at 30°C, while a C-terminal truncation at amino acid 320 was unable to rescue growth [ Fig. 8A , sections 2 to 4, summarized in Fig. 7B , compare yTAF II 65(103-406) and yTAF II 65(103-320)]. At the N terminus, a derivative beginning at amino acid 161 was able to complement growth, but a further deletion up to position 192, which deletes a highly conserved region of the TAPD, abolished function [ Fig. 8A , sections 5 and 6, summarized in Fig. 7B , compare yTAF II 65(161-406) and yTAF II 65 (192-510)]. As all of the viable constructs lacked the HFD, they showed a temperature-sensitive phenotype, being unable to complement at 37°C (data not shown). Therefore, a minimal TAPD between amino acids 161 and 406 is required for yTAF II 65 function.
The minimal domain described above comprises the most conserved regions of the TAPD. To further test the significance of the sequence similarity and to evaluate the relative contributions of the HFD and TAPD to yTAF II 65 function, we deleted or mutated one of the most conserved blocks between amino acids 170 and 200 in the context of wild-type yTAF II 65 and in the context of yTAF II 65 m1, where the HFD is mutated. When this region was deleted in the context of a wild-type HFD, complementation was observed [ Fig. 8B, section 2 , sum- . In contrast, when the deletion was made in the presence of the mutated HFD, which by itself is viable at 30°C (Fig. 8B, section 1) , no growth was observed [Fig. 8B, section 3 , compare yTAF II 65(1-510)m1 with yTAF II 65(1-510)m1⌬]. Similarly, mutation of the highly conserved HTY residues within the region had no effect in the presence of the wild-type HFD but led to a loss of function in the context of a mutated HFD [Fig. 8B , sections 4 and 5, compare yTAF II 65(1-510)m2 and yTAF II 65(1-510)m3, summarized in Fig. 7B ]. Hence, when the HFD is functional, the TAPD can be mutated, and likewise, when the TAPD is intact, the HFD is not absolutely required. These results indicate that yTAF II 65 contains two partially redundant domains. Nevertheless, the HFD seems to play a more important role since its mutation leads to a temperature-sensitive phenotype while mutation or deletion of the TAPD alone does not [compare yTAF II 65m1, yTAF II 65m2, and yTAF II 65(⌬170-200) in Fig.  8C 16 (25) and dTAF II 155 with dTAF II 24. Consequently, the specialization of the dTAF II 16 and dTAF II 24 HFDs has forced the dTAF II 155 and PDS HFDs to also evolve towards a restricted partner choice. This restriction contributes to the relative subunit compositions of the TFIID and GCN5-containing complexes.
TAF II 140 and dTAF II 155 also contain a PHD finger at the C terminus of the protein. The PHD finger is found in almost 300 proteins, most of which are nuclear (39) . The majority of these proteins are involved in transcription and interactions with chromatin, such as the Polycomb-like family, and more recently the ATP-dependent chromatin remodeling factor ACF (1, 41) . Mutations in the PHD fingers of several proteins have been associated with disease (for examples, see references 4 and 20) . The structures of the PHD finger of the WilliamsBeuren syndrome transcription factor (WSTF) and the KAP-1 corepressor have been recently solved by nuclear magnetic resonance and shown to comprise an interleaved zinc finger which binds two zinc ions (9, 39) .
While the function of the PHD finger is unknown, it has been suggested that it is involved in protein-protein interactions. This is the first time a PHD finger has been found in a TFIID subunit, and it may mediate TFIID interactions with chromatin or with chromatin-associated proteins. Its presence in TFIID is particularly intriguing since many of the factors in which it is found are associated with repressor activity, histone deacetylases, and interactions with heterochromatin (for an example, see references 15, 31, and 55). BIP2, however, is not localized on heterochromatin but is associated with transcriptionally active regions of polytene chromosomes. The PHD finger is not the only motif characteristic of chromatin-interacting proteins to be found in TFIID. TAF II 250 contains bromodomains, also found in many chromatin-interacting factors, which have recently been shown to mediate interaction with acetyl-lysine groups in the histone tails (12, 26) . Hence, both the bromodomains and the PHD finger may be interfaces for directing TFIID to promoters within chromatin.
Immunoprecipitations demonstrate that both hTAF II 140 and dTAF II 155 are TFIID subunits, since they are coprecipitated under stringent conditions along with TBP and TAF II s. It has been previously shown that dTAF II 24 is coprecipitated by the dTAF II 16 antisera and vice versa (19) . The simplest interpretation is that both dTAF II 24 and dTAF II 16 are present in the same dTFIID complex containing one (or more) molecules of each. This TFIID would therefore contain both PDS and dTAF II 155. An analogous result was obtained with yeast, where yTAF II 47 can be precipitated from strains expressing a tagged version of yTAF II 65 (45) . These data were supported by immunoelectron microscopy which showed the presence of multiple molecules of yTAF II 65, yTAF II 47, and yTAF II 25 in the same TFIID particle (C. Leurent, S. Sanders, V. Mallouh, P. A. Weil, D. B. Kirschner, L. Tora, and P. Schultz, submitted for publication).
In HeLa cells, hTAF II 30 is a component of both TFIID and TFTC. When HeLa cell nuclear extracts were immunoprecipitated with the anti-TAF II 140 monoclonal antibody, both TFIID-specific components, such as TAF II 18 and TBP, and TFTC-specific components, such as GCN5 and SAP130 (also ADA3 and SPT3; our unpublished data), were detected. The TAF II 30-TAF II 140 heterodimer therefore appears to be a component of both TFIID and TFTC. At first sight this may seem surprising since, in yeast, yTAF II 47 is TFIID specific and is not present in SAGA where the SAGA-specific ySPT7 heterodimerizes with yTAF II 25 (17 (17) .
The evolutionarily conserved TAPD is required for yTAF II 65 function in vivo. Here, we describe the novel TAPD present in yTAF II 65 and PDS. The presence of an HFD and the TAPD in PDS which is known to interact physically and functionally with dTFIID components (25) indicates that PDS is a yTAF II 65 homologue. These domains are also present in the mammalian protein TBN, further suggesting that it may also be a TAF II (25, 51) .
The TAP domain is located C terminal of the HFD, and in yTAF II 65 it is partially redundant with the HFD. In complementation experiments, deletion or mutation of the HFD does not abolish yTAF II 65 function when the TAPD is wild type. Similarly, the TAPD can be mutated or deleted without loss of function when the HFD is present. In contrast, simultaneous mutation of both leads to a loss of function. Hence, the HFD and the TAPD play redundant roles in yTAF II 65 function.
As the function of the yTAF II 65 HFD is to mediate heterodimerization with yTAF II 25 and hence the integration of yTAF II 65 into TFIID, it is likely that the TAPD is also an interface for interactions between yTAF II 65 and another TAF II (s). In the absence of the HFD, the TAPD would allow yTAF II 65 to associate with TFIID and support growth and vice versa. Obviously, when both are mutated, it is no longer possible for yTAF II 65 to interact with the TFIID, and this is lethal for yeast. Note, however, that the HFD seems to be the more critical for yTAF II 65 function, since all the viable strains in which it was deleted had a temperature-sensitive phenotype, whereas the strains in which only the TAPD was mutated grow at 37°C. This is consistent with the fact that histone-like heterodimers are extremely stable and suggests that the interactions mediated by the TAPD are less so. Nonetheless, it is worth noting that the TAPD comprises several conserved sequence blocks, suggesting that it may be composite in nature. Thus, even when amino acids 170 to 200 are deleted or mutated, the remainder of the domain may act cooperatively with the HFD to allow growth at 37°C. We have previously reported that the temperature sensitivity resulting from mutation or deletion of the yTAF II 65 HFD could be selectively suppressed by overexpression of yTAF II 68 (17) . This suggests that the TAPD may interact with yTAF II 68. Biochemical and structural analyses will be required to determine how the TAPD interacts with yTAF II 68 and/or other TFIID components.
In this study, we have proposed that BIP2 (dTAF II 155) and hTAF II 140 are homologues of yTAF II 47 due to the similarity in sequence of the HFDs and their ability to heterodimerize with the yTAF II 25 homologues in dTFIID and hTFIID and that PDS is a homologue of yTAF II 65 based on the shared HFD and TAPD. These results indicate a remarkable conservation of TFIID subunit composition. One notable exception to this is the presence of a PHD finger in hTAF II 140 and its absence in yTAF II 47. Nevertheless, in yeast, the bromodomains and kinase activity in hTAF II 250 are not present in yTAF II 130 (yTAF II 145) but are provided by the association of the Bdf1 and Bdf2 proteins with TFIID (34) . Database searches with the mTAF II 140 and hTAF II 140 PHD finger revealed the presence of several yeast proteins with related PHD fingers. It is possible that, by analogy with Bdf1 and Bdf2, one of these PHD finger-containing proteins associates with yTFIID to provide the missing domain.
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